UKRI are reviewing their systems to better understand the effectiveness of approaches to supporting impact across the Research Councils.
In order to achieve this they have launched a consultation to gather feedback on how impact development activities are being embedded into proposals by applicants. The aim is also to determine the levels of stakeholder involvement, and how impact development activities within proposals are reviewed and assessed. The results from this consultation will be used to make improvements to UKRI’s processes and will be central to the development of a new reference guide on the topic of ‘maximising impact’ within applications, as well as being used as an evidence base for continuous improvement, cross UKRI policy and other UKRI programmes.
They are asking for input from:
- academics
- university research office staff
- users of research
- project partners (such as social enterprises, charities, non-governmental organisations, business)
- other stakeholders.
You can access the survey until 4 February 2022 here.
Reminder: Workshop on including impact in grant applications
Embedding Impact in Funding Applications










BU students’ publishing success
BU presentation at the University of Bristol
Art and Design: History, Practice and Theory academics – would you like to get more involved in preparing our next REF submission?
UKCGE Recognised Research Supervision Programme: Final Deadline Reminder
The significance of Rights and Protocols in Disaster Response
Celebrate World Wellbeing Week This June
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease